The Pre-Treatment Gut Microbiome Predicts Early Response to Methotrexate in Rheumatoid Arthritis

被引：0

作者：

Isaac, Sandrine ^{[1
]}

Artacho, Alejandro ^{[1
]}

Nayak, Renuka ^{[2
]}

Abramson, Steven B. ^{[3
,4
]}

Alexander, Margaret ^{[2
]}

Koo, Imhoi ^{[5
,6
]}

Rosenthal, Pamela ^{[4
]}

Izmirly, Peter ^{[3
]}

Patterson, Andrew ^{[7
]}

Pineda, Antonio ^{[8
]}

Puchades-Carrasco, Leonor ^{[8
]}

Turnbaugh, Peter ^{[2
]}

Ubeda, Carles ^{[9
]}

Scher, Jose ^{[3
]}

机构：

[1] FISABIO, Valencia, Spain

[2] UCSF, San Francisco, CA USA

[3] NYU, Sch Med, New York, NY USA

[4] NYU, Langone Orthoped Hosp, New York, NY USA

[5] Penn State Univ, University Pk, PA 16802 USA

[6] Penn State Huck Inst Life Sci, University Pk, PA USA

[7] Penn State, University Pk, PA USA

[8] Ctr Invest Principe Felipe, Inst Invest Sanitaria La Fe, Valencia, Spain

[9] Ctr Super Invest Salud Publ FISABIO, Valencia, Spain

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2769

引用

页数：2

共 50 条

[31] Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis
Dekkers, Jacqueline S.
Bergstra, Sytske Anne
Chopra, Arvind
Tikly, Mohammed
Fonseca, Joao Eurico
Salomon-Escoto, Karen
Huizinga, Tom W. J.
van der Woude, Diane
RHEUMATOLOGY, 2019, 58 (01) : 149 - 153
[32] AUTOANTIBODY STATUS IS NOT ASSOCIATED WITH EARLY TREATMENT RESPONSE TO FIRST-LINE METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
Dekkerst, J. S.
Bergstra, S. A.
Chopra, A.
Tikly, M.
Fonseca, J. E.
Salomon-Escoto, K.
Huizinga, T.
van der Woude, D.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 843 - 844
[33] The Comparative Effectiveness of Oral Methotrexate versus Subcutaneous Methotrexate for the Treatment of Early Rheumatoid Arthritis
Hazlewood, Glen
Thorne, Carter
Pope, Janet
Boire, Gilles
Haraoui, Los
Hitchon, Carol
Keystone, Edward
Tin, Diane
Bykerk, Vivian
JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 971 - 971
[34] The Comparative Effectiveness of Oral Methotrexate Versus Subcutaneous Methotrexate for the Treatment of Early Rheumatoid Arthritis
Hazlewood, Glen S.
Thorne, J. Carter
Pope, Janet
Boire, Gilles
Haraoui, Boulos
Hitchon, Carol A.
Keystone, Edward
Tin, Diane
Bykerk, Vivian P.
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S202 - S202
[35] Treatment of early seropositive rheumatoid arthritis - Doxycycline plus methotrexate versus methotrexate alone
O'Dell, JR
Elliott, JR
Mallek, JA
Mikuls, TR
Weaver, CA
Glickstein, S
Blakely, KM
Hausch, R
Leff, RD
ARTHRITIS AND RHEUMATISM, 2006, 54 (02): : 621 - 627
[36] The methotrexate therapeutic response in rheumatoid arthritis
Ortendahl, M
Holmes, T
Schettler, JD
Fries, JF
JOURNAL OF RHEUMATOLOGY, 2002, 29 (10) : 2084 - 2091
[37] Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis
Gosselt, Helen R.
Muller, Ittai B.
Jansen, Gerrit
van Weeghel, Michel
Vaz, Frederic M.
Hazes, Johanna M. W.
Heil, Sandra G.
de Jonge, Robert
JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 14
[38] METHOTREXATE IN RHEUMATOID-ARTHRITIS - RESPONSE
NORDSTROM, DM
WEST, SG
ANDERSEN, PA
SHARP, JT
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) : 640 - 641
[39] Prediction of response to methotrexate in rheumatoid arthritis
Ling, Stephanie
Bluett, James
Barton, Anne
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 419 - 429
[40] Time to treatment response with abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate
Kremer, J. M.
Westhovens, R.
Le Bars, M.
Lafosse, C.
Gaillez, C.
Koncz, T.
Schmidely, N.
Dougados, M.
Schiff, M.
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S308 - S308

← 1 2 3 4 5 →